The latest price target for Ekso Bionics Holdings (NASDAQ:EKSO) was reported by HC Wainwright & Co. on July 30, 2024. The analyst firm set a price target for $10.00 expecting EKSO to rise to within 12 months (a possible 733.33% upside). 5 analyst firms have reported ratings in the last year.

The latest analyst rating for Ekso Bionics Holdings (NASDAQ:EKSO) was provided by HC Wainwright & Co., and Ekso Bionics Holdings reiterated their buy rating.

There is no last upgrade for Ekso Bionics Holdings

There is no last downgrade for Ekso Bionics Holdings.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Ekso Bionics Holdings, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Ekso Bionics Holdings was filed on July 30, 2024 so you should expect the next rating to be made available sometime around July 30, 2025.

While ratings are subjective and will change, the latest Ekso Bionics Holdings (EKSO) rating was a reiterated with a price target of $10.00 to $10.00. The current price Ekso Bionics Holdings (EKSO) is trading at is $1.20, which is out of the analyst’s predicted range.